清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

作者
Nikhil Ram-Mohan,David A. Kim,Elizabeth J. Zudock,M Hashemi,Kristel C. Tjandra,Angela J. Rogers,Catherine A. Blish,Kari Christine Nadeau,Jennifer A. Newberry,James Quinn,Ruth M. O'Hara,Euan Angus Ashley,Hien Nguyen,Lingxia Jiang,Paul J. Hung,Andra L. Blomkalns,Samuel S. Yang,Stanford COVID-19 Biobank Study Group,Rosen Mann,Anita Visweswaran
出处
期刊:Clinical Infectious Diseases [Oxford University Press]
卷期号:74 (2): 218-226 被引量:85
标识
DOI:10.1093/cid/ciab394
摘要

Abstract Background The determinants of COVID-19 disease severity and extrapulmonary complications (EPCs) are poorly understood. We characterise the relationships between SARS-CoV-2 RNAaemia and disease severity, clinical deterioration, and specific EPCs. Methods We used quantitative (qPCR) and digital (dPCR) PCR to quantify SARS-CoV-2 RNA from nasopharyngeal swabs and plasma in 191 patients presenting to the Emergency Department (ED) with COVID-19. We recorded patient symptoms, laboratory markers, and clinical outcomes, with a focus on oxygen requirements over time. We collected longitudinal plasma samples from a subset of patients. We characterised the role of RNAaemia in predicting clinical severity and EPCs using elastic net regression. Findings 23·0% (44/191) of SARS-CoV-2 positive patients had viral RNA detected in plasma by dPCR, compared to 1·4% (2/147) by qPCR. Most patients with serial measurements had undetectable RNAaemia 10 days after onset of symptoms, but took 16 days to reach maximum severity, and 33 days for symptoms to resolve. Initially RNAaemic patients were more likely to manifest severe disease (OR 6·72 [95% CI, 2·45 – 19·79]), worsening of disease severity (OR 2·43 [95% CI, 1·07 - 5·38]), and EPCs (OR 2·81 [95% CI, 1·26 – 6·36]). RNA load correlated with maximum severity ( r = 0·47 [95% CI, 0·20 - 0·67]). Interpretation dPCR is more sensitive than qPCR for the detection of SARS-CoV-2 RNAaemia, which is a robust predictor of eventual COVID-19 severity and oxygen requirements, as well as EPCs. Since many COVID-19 therapies are initiated on the basis of oxygen requirements, RNAaemia on presentation might serve to direct early initiation of appropriate therapies for the patients most likely to deteriorate. Funding NIH/NIAID (Grants R01A153133, R01AI137272, and 3U19AI057229 – 17W1 COVID SUPP #2) and a donation from Eva Grove. Research in context Evidence before this study The varied clinical manifestations of COVID-19 have directed attention to the distribution of SARS-CoV-2 in the body. Although most concentrated and tested for in the nasopharynx, SARS-CoV-2 RNA has been found in blood, stool, and numerous tissues, raising questions about dissemination of viral RNA throughout the body, and the role of this process in disease severity and extrapulmonary complications. Recent studies have detected low levels of SARS-CoV-2 RNA in blood using either quantitative reverse transcriptase real-time PCR (qPCR) or droplet digital PCR (dPCR), and have associated RNAaemia with disease severity and biomarkers of dysregulated immune response. Added value of this study We quantified SARS-CoV-2 RNA in the nasopharynx and plasma of patients presenting to the Emergency Department with COVID-19, and found an array-based dPCR platform to be markedly more sensitive than qPCR for detection of SARS-CoV-2 RNA, with a simplified workflow well-suited to clinical adoption. We collected serial plasma samples during patients’ course of illness, and showed that SARS-CoV-2 RNAaemia peaks early, while clinical condition often continues to worsen. Our findings confirm the association between RNAaemia and disease severity, and additionally demonstrate a role for RNAaemia in predicting future deterioration and specific extrapulmonary complications. Implications of all the available evidence Variation in SARS-CoV-2 RNAaemia may help explain disparities in disease severity and extrapulmonary complications from COVID-19. Testing for RNAaemia with dPCR early in the course of illness may help guide patient triage and management.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
清爽笙完成签到,获得积分10
10秒前
无限的寡妇完成签到,获得积分10
20秒前
37秒前
紧张的幼蓉完成签到,获得积分10
39秒前
科研通AI6.4的应助被My_magnum_opus采纳,获得10
48秒前
所所的应助被My_magnum_opus采纳,获得50
49秒前
NexusExplorer的应助被My_magnum_opus采纳,获得10
49秒前
orixero的应助被My_magnum_opus采纳,获得100
49秒前
SciGPT的应助被My_magnum_opus采纳,获得10
49秒前
49秒前
科研通AI65的应助被My_magnum_opus采纳,获得10
50秒前
科研通AI6.3的应助被My_magnum_opus采纳,获得10
50秒前
胡萝卜完成签到,获得积分10
57秒前
长情招牌完成签到,获得积分10
1分钟前
外向的小海豚完成签到,获得积分10
1分钟前
靓丽雪萍完成签到,获得积分10
1分钟前
1分钟前
1分钟前
ZLPY发布了新的文献求助10
1分钟前
ZLPY完成签到,获得积分10
1分钟前
1分钟前
美满尔蓝完成签到,获得积分10
1分钟前
1分钟前
虚幻百招完成签到,获得积分10
1分钟前
认真雨寒完成签到,获得积分10
2分钟前
英俊的铭的应助被TingtingGZ采纳,获得10
2分钟前
Qian完成签到 ,获得积分10
2分钟前
火星上的山柳完成签到,获得积分10
2分钟前
结实映容完成签到,获得积分10
2分钟前
yan完成签到,获得积分10
2分钟前
美好傲蕾完成签到,获得积分10
2分钟前
腼腆的冰安完成签到,获得积分10
2分钟前
舒适的妍完成签到,获得积分10
2分钟前
Maestro_S的应助被科研通管家采纳,获得10
2分钟前
Maestro_S的应助被科研通管家采纳,获得10
2分钟前
沐雨汐完成签到,获得积分10
2分钟前
mycn完成签到,获得积分10
2分钟前
悦耳向松完成签到,获得积分10
2分钟前
温柔的海秋完成签到,获得积分10
2分钟前
丰富广缘完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780496
捐赠科研通 7767299
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476688